(Q34253268)

31 July 2017

1 reference

title

New insights into progressive supranuclear palsy (English)

1 reference

31 July 2017

Albers DS

1

1 reference

31 July 2017

Augood SJ

series ordinal

2

1 reference

31 July 2017

publication date

1 June 2001

1 reference

31 July 2017

published in

Trends in Neurosciences

1 reference

31 July 2017

volume

24

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

347-353

1 reference

Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Progressive supranuclear palsy: a survey of the disease course.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Prevalence and natural history of progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

PET studies in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

The subthalamic nucleus in Parkinson's disease and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Substructure of 20 nm filaments of progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Large neurons in the neostriatum in Alzheimer's disease and progressive supranuclear palsy: a topographic, histologic and ultrastructural investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Loss of the dentate nucleus neurons is associated with torpedo formation: a morphometric study in progressive supranuclear palsy and dentatorubro-pallidoluysian atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Clinical genetics of familial progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Genetic evidence for the involvement of tau in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Association of an extended haplotype in the tau gene with progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Mutational analysis of the tau gene in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

An extended 5'-tau susceptibility haplotype in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Apolipoprotein E epsilon 4 allele frequency is not increased in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Astrocytic pathology in progressive supranuclear palsy: significance for neuropathological diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Tau mutations cause frontotemporal dementias

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Tau protein pathology in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Energetics in the pathogenesis of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Evidence for oxidative stress in the subthalamic nucleus in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Frontal lobe dysfunction in progressive supranuclear palsy: evidence for oxidative stress and mitochondrial impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Lipoperoxidation is selectively involved in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Inducible nitric oxide synthase (iNOS)-like immunoreactivity in argyrophilic, tau-positive astrocytes in progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

New insights into the cause of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Brain amino acids and glutathione in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Nitric oxide activates metalloprotease enzymes in articular cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Matrix metalloproteinases and diseases of the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

C-terminal alpha-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Deficit of brain and skeletal muscle bioenergetics in progressive supranuclear palsy shown in vivo by phosphorus magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Muscle mitochondrial ATP production in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Low brain intracellular free magnesium in mitochondrial cytopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Further evidence for mitochondrial dysfunction in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Requirement for superoxide in excitotoxic cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Nitric oxide and mitochondrial respiration

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Nitric oxide and iron proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Alternative excitotoxic hypotheses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

Neurofibrillary tangles in progressive supranuclear palsy brains exhibit immunoreactivity to frameshift mutant ubiquitin-B protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901794-X

7 January 2021

10.1016/S0166-2236(00)01794-X

Identifiers

DOI

1 reference

31 July 2017

1 reference